Yan‐Jun Xiang

494 citations
28 papers · 318 · 1 hit paper · h-index 11

Impact in

  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 23
    • Cholangiocarcinoma and Gallbladder Cancer Studies 3

Yan‐Jun Xiang

26 papers receiving 316 citations

Yan‐Jun Xiang's Hit Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial 2024 · 77 citations
770+1Years since publication255075

Peers

Yan‐Jun Xiang
Comparison fields: 5 of 31
  • Hepatology 241
  • Oncology 48
  • Pathology and Forensic Medicine 30
  • Cancer Research 18
  • Parasitology 8
Replace Kazuharu Yamamoto with:
Kazuharu Yamamoto Japan
Guosheng Yuan China
Yabing Guo China
Éric Assenat France
Wenbo Guo China
Kathryn D’Addeo United States
Vincent E. Gaillard Switzerland
Dongbo Xu China
Mallory Makowsky United States
Michinori Hamaoka Japan
Yan‐Jun Xiang relative to Kazuharu Yamamoto Japan Kazuharu Yamamoto's profile →
Citations per field
00.5×20×40×61.5×
Kazuharu Yamamoto · 1×
Citations per year

Countries citing papers authored by Yan‐Jun Xiang

Since Specialization
Citations

This map shows the geographic impact of Yan‐Jun Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Jun Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Jun Xiang more than expected).

Fields of papers citing papers by Yan‐Jun Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Jun Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Jun Xiang. The network helps show where Yan‐Jun Xiang may publish in the future.

Co-authors

The 25 scholars most cited alongside Yan‐Jun Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yan‐Jun Xiang Line = papers co-authored together Yan‐Jun Xiang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
Hit paper breakdown →
202477
2 202235
3 202324
4 202322
5 202219
6 202318
7 202115
8 202214
9
A study and analysis of the deaths due to advanced Schistosoma japonicum infection in the Dongting Lake area of China.
199312
10 202311
11 202211
12 20238
13 20247
14 20236
15 20236
16 20234
17 20234
18 20234
19 20224
20 20213

About Yan‐Jun Xiang

Yan‐Jun Xiang is a scholar working on Hepatology, Surgery, Epidemiology, Pathology and Forensic Medicine and Oncology, having authored 28 papers that have together received 318 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (23 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Mechanisms and Therapy (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Airway Management and Intubation Techniques (1 paper) and Advanced X-ray and CT Imaging (1 paper). The work is most often cited by research in Hepatology (241 citations), Oncology (48 citations), Pathology and Forensic Medicine (30 citations), Cancer Research (18 citations) and Parasitology (8 citations). Yan‐Jun Xiang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Kang Wang, Yuqiang Cheng, Hongming Yu, Shuqun Cheng, Jin-Kai Feng, Wei‐Xing Guo, Shuqun Cheng, Jie Shi, Liping Zhou and Yingyi Qin. Their work appears in journals such as Frontiers in Oncology, Cancer Medicine, BMC Cancer, Hepatology Research and Hepatology International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact